James McLean
Presidente presso AROA BIOSURGERY LIMITED
Patrimonio netto: 917 905 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James Agnew | M | - | 11 anni | |
| Brian Ward | M | - | 16 anni | |
| John Pinion | M | 58 | 9 anni | |
| John Diddams | M | - | 5 anni | |
| Catherine Mohr | M | 56 | 2 anni | |
| Philip McCaw | M | - |
Mesynthes Nominee Ltd.
| 16 anni |
| Rod Stanley | M | - | 11 anni | |
| Barnaby May | M | - | 16 anni | |
| Patrick Hunt | M | - | 6 anni | |
| Scott Sherriff | M | - | 1 anni | |
| Sarah Tora | F | - | - | |
| Rachel Stuart | F | - | 2 anni | |
| Simon Hinsley | M | - | - | |
| Neetha Alex-Kumar | F | - | 3 anni | |
| Frazer Murray | M | - | 4 anni | |
| Brad Adams | M | - | 5 anni | |
| Tim Goodacre | M | - |
Prevar Ltd.
| - |
| Tracy Weimar | F | - | - | |
| Yasmin Winchester | F | - | 10 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Stephen G. Hall | M | - |
Genesis Research & Development Corp. Ltd.
 Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
| Steven Engle | M | 69 | 9 anni | |
| Andrew John Hubert Gearing | M | - |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 anni |
| Stewart Washer | M | 54 |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 anni |
| Douglas Williams | M | 66 |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 1 anni |
| Joachim von Roy | M | 79 |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
| Nivedita Findlay | F | - |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 anni |
| Ewe Poh Lim | F | - |
Genesis Research & Development Corp. Ltd.
Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
| Simone von Fircks | F | - | - | |
| Caroline Quay | F | - | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Nuova-Zelanda | 29 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- James McLean
- Contatti personali
